IP Library Granted Patent US 10,206,892
Granted Patent B2
US 10,206,892 · App. 15/939,445 · Granted Feb 19, 2019

Topical compositions for pain relief, manufacture and use

Inventors: Philip J. Birbara (West Hartford, CT); Daniel Bucks (Millbrae, CA)
Assignee: VIZURI HEALTH SCIENCES LLC
A61K31/165A61K9/0014A61K9/06A61K9/08A61K31/00A61K31/045A61K31/05A61K31/125A61K31/618A61K31/728A61K45/06A61K47/10A61K47/26A61K47/36A61K47/42A61K47/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,206,892
App. No.
15/939,445
Granted
Feb 19, 2019
Kind
B2
Abstract

The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.

Claims (23)

1. A method of treating pain in a mammal suffering from pain comprising topically administering a composition to said mammal, the composition comprising

i) 0.075-20% by weight of a capsaicinoid,

ii) an extended release agent to slow the release of said capsaicinoid from said composition upon administration of said composition to a mammal, and

iii) a surfactant.

2. A method as in claim 1 wherein said mammal is a human.

3. A method as in claim 1 further comprising administering an NSAID.

4. A method as in claim 1 wherein said pain is arthritis pain.

5. A method as in claim 4 wherein said arthritis pain is osteoarthritis or rheumatoid arthritis pain.

6. A method of treating a capsaicin responsive condition in a mammal suffering from said condition comprising topically administering a composition to said mammal, the composition comprising

i) 0.075-20% by weight of a capsaicinoid,

ii) an extended release agent to slow the release of said capsaicinoid from said composition upon administration of said composition to a mammal, and

iii) a surfactant.

7. A method as in claim 6 wherein the capsaicin responsive condition is pain including neuropathic pain, inflammatory hyperalgia, vulvodynia, interstitial cystitis, rhinitis, burning mouth syndrome, oral mucositis, herpes, dermatitis, pruritus, tinnitus, psoriasis, or headaches.

8. A method of treating itching in a mammal comprising topically administering a composition, the composition comprising

i) 0.075-20% by weight of a capsaicinoid,

ii) an extended release agent to slow the release of said capsaicinoid from said composition upon administration of said composition to a mammal, and

iii) a surfactant.

9. A method of formulating an aqueous capsaicinoid formulation comprising:

i) dissolving a capsaicinoid in a surfactant to form a solution, and

ii) adding hyaluronic acid to the solution.

10. A method of producing an aqueous topical formulation of capsaicin comprising:

i) mixing a capsaicinoid and a surfactant and ethanol, and

ii) adding hyaluronic acid.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2025
From: ASTELLAS US LLC
To: JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD.
Reel/Frame 072378/0590 →
MERGER Recorded Nov 15, 2024
From: PROPELLA THERAPEUTICS, INC.
To: ASTELLAS US LLC
Reel/Frame 069281/0486 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2020
From: VIZURI HEALTH SCIENCES LLC
To: PROPELLA THERAPEUTICS, INC.
Reel/Frame 052939/0276 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2018
From: BIRBARA, CAROL; BUCKS, DANIEL
To: VIZURI HEALTH SCIENCES LLC
Reel/Frame 045382/0299 →
Continuity (3)
Division 14687566 · Apr 15, 2015
Provisional Application 61979905 · Apr 15, 2014
Related Publication 20180214398A1 · Aug 2, 2018